The Breathe Study

Study Objective:

• The study medication is a potential new treatment designed to improve the biology of COPD and enhance lung function. Administered via a single subcutaneous injection, this medication represents a significant step forward in the fight against this debilitating disease.
• The goal of the study medication is to be more effective than the current treatments that are available triggering fewer side effects.

Importance of Treatment:

• In 2022, COPD was responsible for over 4% of all deaths in Australia, highlighting the urgent need for effective treatments.
• Your involvement could play a crucial role in advancing COPD treatment and potentially transforming the lives of those affected by this condition.

Clinical Trial Details:

• An independent ethics committee has approved this clinical trial.
• Participants will be reimbursed for their time
  

Call us on 1800 243 733 to discuss your eligibility today!